CD151 and B-cell non-Hodgkin lymphoma: CD151 expression has been well-established to correlate with poor prognosis for patients with different solid cancer types due to enhanced metastasis among other mechanisms, but this has not yet been established for B-cell non-Hodgkin lymphoma [18, 37].